Stock listing
Frankfurt:AP82 Aptevo Therapeutics Inc. Aktie
German listing (Frankfurt) of Aptevo Therapeutics Inc. · home listing NASDAQ:APVO
Follow Aptevo Therapeutics Inc. into a list and get an email when it puts out news.
Home listing price · NASDAQ:APVO
$1.34 USD -0.02 (-1.5%)
Close on Oct 30, 2026 · This listing has no price on 6ix; the price shown is the home listing's, NASDAQ:APVO
- Day range
- $1.31 – $1.39 USDOct 30, 2026
- Volume
- 16,897 sharesOct 30, 2026
- Market cap
- $2.43M USDAt the close on Oct 30, 2026 · price × 1.81M shares outstanding
- 52-week range
- $1.25 – $28.44 USDLowest and highest trades, Oct 31, 2025 – Oct 30, 2026
- Traded on an average day
- $194,977 USDMedian day 33,400 shares · last 3 months, Jul 30, 2026 – Oct 30, 2026
Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NASDAQ:APVO · Home | $1.34 USD | -0.02 (-1.5%) | 16,897 | $1.36 | $1.386 | $1.31 | $1.36 | Close on Oct 30, 2026 |
Daily closes
Last 3 months, Jul 30, 2026 – Oct 30, 2026 · NASDAQ:APVO · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $1.34 | -0.02 | -1.5% | $1.36 | $1.386 | $1.31 | 16,897 | |
| $1.36 | +0.06 | +4.6% | $1.32 | $1.41 | $1.31 | 58,513 | |
| $1.30 | +0.02 | +1.6% | $1.36 | $1.37 | $1.26 | 42,174 | |
| $1.28 | -0.22 | -14.7% | $1.55 | $1.58 | $1.253 | 79,957 | |
| $1.50 | -0.11 | -6.8% | $1.74 | $1.74 | $1.44 | 123,546 | |
| $1.61 | 0.00 | 0.0% | $1.61 | $1.636 | $1.60 | 7,200 | |
| $1.61 | +0.01 | +0.6% | $1.605 | $1.64 | $1.60 | 5,300 | |
| $1.60 | -0.015 | -0.9% | $1.63 | $1.65 | $1.60 | 8,600 | |
| $1.615 | +0.015 | +0.9% | $1.60 | $1.65 | $1.60 | 12,600 | |
| $1.60 | -0.02 | -1.2% | $1.655 | $1.655 | $1.568 | 8,400 | |
| $1.62 | -0.08 | -4.7% | $1.73 | $1.73 | $1.60 | 31,100 | |
| $1.70 | -0.03 | -1.7% | $1.73 | $1.74 | $1.70 | 10,800 | |
| $1.73 | 0.00 | 0.0% | $1.73 | $1.78 | $1.71 | 21,900 | |
| $1.73 | -0.106 | -5.8% | $1.79 | $1.79 | $1.70 | 85,700 | |
| $1.836 | +0.046 | +2.6% | $1.79 | $1.97 | $1.76 | 282,300 | |
| $1.79 | -0.01 | -0.6% | $1.79 | $1.81 | $1.78 | 6,700 | |
| $1.80 | -0.04 | -2.2% | $1.77 | $1.84 | $1.77 | 26,700 | |
| $1.84 | +0.045 | +2.5% | $1.76 | $1.85 | $1.76 | 12,100 | |
| $1.795 | -0.005 | -0.3% | $1.82 | $1.92 | $1.79 | 35,400 | |
| $1.80 | +0.04 | +2.3% | $1.76 | $1.85 | $1.75 | 28,100 | |
| $1.76 | 0.00 | 0.0% | $1.80 | $1.80 | $1.76 | 12,600 | |
| $1.76 | -0.06 | -3.3% | $1.82 | $1.84 | $1.75 | 25,000 | |
| $1.82 | -0.04 | -2.2% | $1.84 | $1.90 | $1.81 | 24,100 | |
| $1.86 | -0.05 | -2.6% | $1.90 | $1.91 | $1.84 | 15,000 | |
| $1.91 | +0.02 | +1.1% | $1.86 | $1.98 | $1.86 | 47,000 | |
| $1.89 | +0.06 | +3.3% | $1.83 | $1.90 | $1.818 | 25,500 | |
| $1.83 | -0.06 | -3.2% | $1.88 | $1.90 | $1.81 | 33,000 | |
| $1.89 | +0.04 | +2.2% | $1.88 | $1.895 | $1.80 | 53,300 | |
| $1.85 | +0.04 | +2.2% | $1.814 | $1.89 | $1.814 | 39,200 | |
| $1.81 | -0.03 | -1.6% | $1.842 | $1.89 | $1.805 | 22,400 | |
| $1.84 | 0.00 | 0.0% | $1.85 | $1.89 | $1.82 | 40,800 | |
| $1.84 | +0.12 | +7.0% | $1.79 | $1.90 | $1.73 | 423,800 | |
| $1.72 | +0.01 | +0.6% | $1.711 | $1.80 | $1.711 | 54,000 | |
| $1.71 | -0.09 | -5.0% | $1.81 | $1.84 | $1.71 | 48,300 | |
| $1.80 | -0.02 | -1.1% | $1.854 | $1.895 | $1.80 | 46,100 | |
| $1.82 | -0.01 | -0.5% | $1.83 | $1.92 | $1.80 | 43,600 | |
| $1.83 | -0.015 | -0.8% | $1.82 | $1.88 | $1.76 | 56,500 | |
| $1.845 | -0.035 | -1.9% | $1.89 | $1.99 | $1.82 | 43,900 | |
| $1.88 | +0.14 | +8.0% | $1.77 | $1.93 | $1.745 | 168,100 | |
| $1.74 | +0.03 | +1.8% | $1.74 | $1.796 | $1.64 | 272,100 | |
| $1.71 | -0.89 | -34.2% | $2.11 | $2.18 | $1.37 | 1,689,600 | |
| $2.60 | +0.26 | +11.1% | $2.34 | $2.77 | $2.33 | 1,027,600 | |
| $2.34 | -0.10 | -4.1% | $2.44 | $2.44 | $2.34 | 32,000 | |
| $2.44 | +0.075 | +3.2% | $2.35 | $2.45 | $2.35 | 29,700 | |
| $2.365 | -0.055 | -2.3% | $2.46 | $2.46 | $2.31 | 21,500 | |
| $2.42 | +0.01 | +0.4% | $2.41 | $2.42 | $2.34 | 35,100 | |
| $2.41 | -0.05 | -2.0% | $2.49 | $2.55 | $2.41 | 27,600 | |
| $2.46 | +0.05 | +2.1% | $2.37 | $2.50 | $2.301 | 58,598 | |
| $2.41 | -0.27 | -10.1% | $2.76 | $2.76 | $2.38 | 194,986 | |
| $2.68 | -0.08 | -2.9% | $2.84 | $2.85 | $2.58 | 54,100 | |
| $2.76 | +0.03 | +1.1% | $2.74 | $2.912 | $2.723 | 63,800 | |
| $2.73 | -0.17 | -5.9% | $2.99 | $3.01 | $2.60 | 92,600 | |
| $2.90 | +0.09 | +3.2% | $2.82 | $2.90 | $2.68 | 48,600 | |
| $2.81 | -0.13 | -4.4% | $2.99 | $2.99 | $2.81 | 54,700 | |
| $2.94 | -0.46 | -13.5% | $3.40 | $3.40 | $2.84 | 79,300 | |
| $3.40 | -0.10 | -2.9% | $3.504 | $3.56 | $3.35 | 33,800 | |
| $3.50 | -0.636 | -15.4% | $4.02 | $4.02 | $3.50 | 147,900 | |
| $4.136 | +0.116 | +2.9% | $4.08 | $4.155 | $4.01 | 5,119 | |
| $4.02 | -0.16 | -3.8% | $4.113 | $4.18 | $4.02 | 14,583 | |
| $4.18 | +0.11 | +2.7% | $4.12 | $4.20 | $4.10 | 10,400 | |
| $4.07 | -0.12 | -2.9% | $4.109 | $4.11 | $3.96 | 25,100 | |
| $4.19 | +0.10 | +2.4% | $4.114 | $4.19 | $4.01 | 3,800 | |
| $4.09 | +0.14 | +3.5% | $3.95 | $4.18 | $3.95 | 8,500 | |
| $3.95 | -0.16 | -3.9% | $4.08 | $4.08 | $3.90 | 11,700 | |
| $4.11 | -0.02 | -0.5% | $4.07 | $4.11 | $4.07 | 10,300 | |
| $4.13 | +0.15 | +3.8% | $4.085 | $4.21 | $3.90 | 11,200 |
- Ticker
- Frankfurt:AP82
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- Frankfurt
- Currency
- EUR
What changed lately
Latest news
Aptevo Reports Mipletamig Combination Therapy Enabled 21% of Frontline AML Patients to Advance to Potentially Curative Stem Cell Transplant
Oct 26, 2026
Closed $1.50 (-6.8%) on Oct 26, 2026
Aptevo to Showcase Multispecific Platform at SITC 2026 Annual Meeting
Oct 14, 2026
Closed $1.73 (0.0%) on Oct 14, 2026
Aptevo Reports 93% Clinical Benefit Rate with Mipletamig Triplet in Difficult-to-Treat TP53-Mutated Frontline AML
Sep 3, 2026
Closed $1.71 (-34.2%) on Sep 3, 2026
Aptevo Provides 2Q26 Business Update and Reports Second Quarter Financial Results
Aug 14, 2026
Closed $2.94 (-13.5%) on Aug 14, 2026
Aptevo Therapeutics Announces Closing of Existing Warrants Exercise and PIPE for $4.5 Million Gross Proceeds
Aug 13, 2026
Closed $2.94 (-13.5%) on Aug 14, 2026
Aptevo Therapeutics Announces Exercise of Existing Warrants and PIPE for $4.5 Million Gross Proceeds
Aug 12, 2026
Closed $3.50 (-15.4%) on Aug 12, 2026
As Big Pharma Bets On Radiopharmaceuticals, Aptevo And Niowave Join Forces To Advance Novel Targeted Cancer Therapeutics In The $17B+ Oncology Category
Jun 9, 2026
Closed $4.76 (-2.7%) on Jun 9, 2026
Aptevo Therapeutics Appoints Mary J. Janatpour, Ph.D., as Senior Vice President & Chief Scientific Officer
May 28, 2026
Closed $5.00 (+3.3%) on May 28, 2026
Aptevo and Niowave Launch Strategic Collaboration for Radiopharmaceutical Therapeutic Development, Includes Strategic Equity Investment by Niowave at Closing
May 27, 2026
Closed $4.84 (-1.0%) on May 27, 2026
Aptevo Therapeutics Provides a 1Q26 Business Update; RAINIER on Track for 2026 Completion and Phase 2 Dose Selection
May 13, 2026
Closed $4.76 (-1.4%) on May 13, 2026
Financings
Common stock on exercise of existing warrants
Aug 13, 2026
Closed: US$4.03 a share · Warrants at US$4.03 for 60 months · Roth Capital Partners, LLC
Dealers: Roth Capital Partners, LLC (lead)
Use of proceeds: Working capital
Private placement of unregistered shares of common stock (or pre-funded warrants) with common warrants
Aug 13, 2026
Closed: US$4.03 a share · Warrants at US$4.03 for 60 months · Roth Capital Partners, LLC
Dealers: Roth Capital Partners, LLC (lead)
Use of proceeds: Working capital
Decks
Investor Presentation (March 2025)
Investor deck · 27 slides · Mar 20, 2025
Investor Presentation (February 2025)
Investor deck · 30 slides · Feb 11, 2025
Investor Presentation (January 2019)
Investor deck · 31 slides · Jan 9, 2019
Investor Presentation (January 2018)
Investor deck · 38 slides · Jan 8, 2018
Aptevo Therapeutics Inc. on 6ix
- Sector
- Health care
- Industry
- Biotechnology
- News releases
- 19 in the last 12 months · 96 in all · newest Oct 26, 2026 · oldest 2019
- Decks
- 10 decks · latest Mar 20, 2025
Where Aptevo Therapeutics Inc. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NASDAQ:APVO · Home listing | NASDAQ | United States | USD |
| BOATS:APVO | BOATS | United States | USD |
| gettex:AP82 | gettex | Germany | EUR |
| Frankfurt:AP82 · This page | Frankfurt | Germany | EUR |
| Munich:AP82 | Munich | Germany | EUR |
Log in to ask 6ix AI your own questions about Aptevo Therapeutics Inc.